These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5162747)

  • 21. Access to generic drugs in the 1950s: the politics of a social problem.
    Facchinetti NJ; Dickson WM
    Am J Public Health; 1982 May; 72(5):468-75. PubMed ID: 7065335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brands or generics: the dilemma of pharmaceutical marketing in a developing country.
    Quraeshi ZA; Luqmani M; Malhotra N
    J Health Care Mark; 1983; 3(4):27-37. PubMed ID: 10264767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The law--what it is and isn't.
    Simonsmeier LM
    Pharm Manage Comb Am J Pharm; 1979; 151(1):25-6. PubMed ID: 441138
    [No Abstract]   [Full Text] [Related]  

  • 26. State regulatory positions concerning therapeutic substitutions in hospitals.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1900-3. PubMed ID: 7325169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caution: drug substitution can be hazardous to patient health. Repeal of patient protection statutes has resulted in therapeutic failures.
    Todd MC
    J Indiana State Med Assoc; 1976 Nov; 69(11):801-2. PubMed ID: 993609
    [No Abstract]   [Full Text] [Related]  

  • 28. Report of the Committee on Anti-Substitution Policy.
    Am J Pharm Sci Support Public Health; 1971; 143(6):195-200. PubMed ID: 5140168
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic substitution and better purchasing significantly reduce hospital pharmacy costs.
    Perry PA
    Hosp Mater Manage; 1990 Jan; 15(1):10-1. PubMed ID: 10103376
    [No Abstract]   [Full Text] [Related]  

  • 30. NY court boosts non-branded care.
    Horty JF
    Mod Healthc; 1982 Oct; 12(10):148. PubMed ID: 10256958
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic substitution: has its time arrived?
    Doering PL; Russell WL; Klapp DL; McCormick WC
    Hosp Formul; 1984 Sep; 19(9):834-5 ,838-40. PubMed ID: 10267930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Welty TE
    Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacy law as it applies to handling of drugs.
    Rogers JO
    J Am Coll Health Assoc; 1969 Dec; 18(2):165. PubMed ID: 5406714
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacy and the law: a pharmacist/lawyer perspective.
    Zarranz JA
    Hosp Mater Manage Q; 1985 Feb; 6(3):38-49. PubMed ID: 10269732
    [No Abstract]   [Full Text] [Related]  

  • 35. An examination of drug product substitution in Texas two years after enactment of legislation.
    Shepherd MD; Pongcharoensuk P
    J Pharm Mark Manage; 1986; 1(2):97-108. PubMed ID: 10282753
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent trends in pharmacy law and regulation.
    Brushwood DB
    Pharm Hist; 2009; 51(3):98-102. PubMed ID: 20527203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interchange of bioequivalent drugs].
    Muñoz de Quiñones A
    Bol Col Prof Enferm P R; 1982 Sep; 8(31):15-6. PubMed ID: 6965000
    [No Abstract]   [Full Text] [Related]  

  • 38. States moving to allow generic substitution.
    Internist; 1979 May; 20(4):12-3. PubMed ID: 10242129
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.
    Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM
    Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic substitution and the hospital formulary system.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1949-51. PubMed ID: 7325179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.